Frequency Therapeutics: Falls as Q1 net loss widens, revenue misses

Korro Bio

13/05/2021 17:06

** Drug developer's shares  FREQ.O  fall 9% to $9.19
    ** Co's Q1 net loss widens to $20.4 mln from $4.9 mln a year
earlier  urn:newsml:reuters.com:*:nBw4sjmJVa
    ** Research and development expenses more than double to
$15.1 mln due to increased costs related to co's lead product
candidate, FX-322
    ** Q1 revenue of $4.7 mln falls short of Refinitiv IBES
estimates of $8.1 mln
    ** FREQ had fallen 71.4% YTD, up to last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))